225 related articles for article (PubMed ID: 8510232)
1. Use of fluorescent in situ hybridization for deoxyribonucleic acid ploidy analysis of prostatic adenocarcinoma.
Persons DL; Gibney DJ; Katzmann JA; Lieber MM; Farrow GM; Jenkins RB
J Urol; 1993 Jul; 150(1):120-5. PubMed ID: 8510232
[TBL] [Abstract][Full Text] [Related]
2. Comparison of fluorescence in situ hybridization with flow cytometry and static image analysis in ploidy analysis of paraffin-embedded prostate adenocarcinoma.
Persons DL; Takai K; Gibney DJ; Katzmann JA; Lieber MM; Jenkins RB
Hum Pathol; 1994 Jul; 25(7):678-83. PubMed ID: 8026827
[TBL] [Abstract][Full Text] [Related]
3. Chromosomal aneusomies detected by fluorescent in situ hybridization analysis in clinically localized prostate carcinoma.
Brown JA; Alcaraz A; Takahashi S; Persons DL; Lieber MM; Jenkins RB
J Urol; 1994 Oct; 152(4):1157-62. PubMed ID: 8072085
[TBL] [Abstract][Full Text] [Related]
4. Comparison of fluorescence in situ hybridization and flow cytometric DNA ploidy analysis in paraffin-embedded prostatic adenocarcinoma specimens.
Lifson B; Pizzolo JG; Elhosseiny AA; Choudhury MS; Melamed MR
Anal Quant Cytol Histol; 1995 Apr; 17(2):93-9. PubMed ID: 7542002
[TBL] [Abstract][Full Text] [Related]
5. Numeric alterations in chromosomes 7 and 8 detected by fluorescent in situ hybridization correlate with high-grade localized prostate cancer.
Barranco MA; Alcaraz A; Corral JM; Solé M; Mallofré C; Llopis J; Rodríguez A; Ribal MJ; Alvarez-Vijande R; Carretero P
Eur Urol; 1998; 34(5):419-25. PubMed ID: 9803005
[TBL] [Abstract][Full Text] [Related]
6. Value of nuclear DNA ploidy patterns in patients with prostate cancer after radical prostatectomy.
Wirth MP; Müller HA; Manseck A; Müller J; Frohmüller HG
Eur Urol; 1991; 20(3):248-52. PubMed ID: 1823048
[TBL] [Abstract][Full Text] [Related]
7. Sensitive detection of chromosome copy number aberrations in prostate cancer by fluorescence in situ hybridization.
Visakorpi T; Hyytinen E; Kallioniemi A; Isola J; Kallioniemi OP
Am J Pathol; 1994 Sep; 145(3):624-30. PubMed ID: 8080044
[TBL] [Abstract][Full Text] [Related]
8. Stage D1 prostatic adenocarcinoma: significance of nuclear DNA ploidy patterns studied by flow cytometry.
Winkler HZ; Rainwater LM; Myers RP; Farrow GM; Therneau TM; Zincke H; Lieber MM
Mayo Clin Proc; 1988 Feb; 63(2):103-12. PubMed ID: 3339904
[TBL] [Abstract][Full Text] [Related]
9. Relationship between chromosomal instability and intratumoral regional DNA ploidy heterogeneity in primary gastric cancers.
Furuya T; Uchiyama T; Murakami T; Adachi A; Kawauchi S; Oga A; Hirano T; Sasaki K
Clin Cancer Res; 2000 Jul; 6(7):2815-20. PubMed ID: 10914729
[TBL] [Abstract][Full Text] [Related]
10. Potential markers of prostate cancer aggressiveness detected by fluorescence in situ hybridization in needle biopsies.
Takahashi S; Qian J; Brown JA; Alcaraz A; Bostwick DG; Lieber MM; Jenkins RB
Cancer Res; 1994 Jul; 54(13):3574-9. PubMed ID: 8012984
[TBL] [Abstract][Full Text] [Related]
11. Fluorescence in situ hybridization aneuploidy as a predictor of clinical disease recurrence and prostate-specific antigen level 3 years after radical prostatectomy.
Brown JA; Slezak JM; Lieber MM; Jenkins RB
Mayo Clin Proc; 1999 Dec; 74(12):1214-20. PubMed ID: 10593349
[TBL] [Abstract][Full Text] [Related]
12. Comparison of fluorescence in situ hybridization analysis of isolated nuclei and routine histological sections from paraffin-embedded prostatic adenocarcinoma specimens.
Qian J; Bostwick DG; Takahashi S; Borell TJ; Brown JA; Lieber MM; Jenkins RB
Am J Pathol; 1996 Oct; 149(4):1193-9. PubMed ID: 8863668
[TBL] [Abstract][Full Text] [Related]
13. Nuclear deoxyribonucleic acid ploidy and serum prostate specific antigen in operable prostatic adenocarcinoma.
Nativ O; Myers RP; Farrow GM; Therneau TM; Zincke H; Lieber MM
J Urol; 1990 Aug; 144(2 Pt 1):303-6. PubMed ID: 1695690
[TBL] [Abstract][Full Text] [Related]
14. Interphase cytogenetics of prostatic adenocarcinoma and precursor lesions: analysis of 25 radical prostatectomies and 17 adjacent prostatic intraepithelial neoplasias.
Alers JC; Krijtenburg PJ; Vissers KJ; Bosman FT; van der Kwast TH; van Dekken H
Genes Chromosomes Cancer; 1995 Apr; 12(4):241-50. PubMed ID: 7539277
[TBL] [Abstract][Full Text] [Related]
15. Stage C prostatic adenocarcinoma: flow cytometric nuclear DNA ploidy analysis.
Nativ O; Winkler HZ; Raz Y; Therneau TM; Farrow GM; Myers RP; Zincke H; Lieber MM
Mayo Clin Proc; 1989 Aug; 64(8):911-9. PubMed ID: 2796401
[TBL] [Abstract][Full Text] [Related]
16. Ploidy analysis in paraffin-embedded malignant fibrous histiocytoma by DNA cytofluorometry and flourescence in situ hybridization.
Murata H; Kusuzaki K; Hirasawa Y; Inazawa J; Abe T; Ashihara T
Cancer Lett; 1997 Sep; 118(1):123-8. PubMed ID: 9310269
[TBL] [Abstract][Full Text] [Related]
17. DNA ploidy in prostate cancer: potential measurement as a surrogate endpoint biomarker.
Lieber MM
J Cell Biochem Suppl; 1994; 19():246-8. PubMed ID: 7529855
[TBL] [Abstract][Full Text] [Related]
18. Flow cytometric determination of ploidy in prostatic adenocarcinoma: a comparison with seminal vesicle involvement and histopathological grading as a predictor of clinical recurrence.
Lee SE; Currin SM; Paulson DF; Walther PJ
J Urol; 1988 Oct; 140(4):769-74. PubMed ID: 3047437
[TBL] [Abstract][Full Text] [Related]
19. Correlation of DNA ploidy and histologic diagnosis from prostate core-needle biopsies: is DNA ploidy more sensitive than histology for the diagnosis of carcinoma in small specimens?
Lo J; Kerns BJ; Amling CL; Robertson CN; Layfield LJ
J Surg Oncol; 1996 Sep; 63(1):41-5. PubMed ID: 8841465
[TBL] [Abstract][Full Text] [Related]
20. Alteration of numerical chromosomal aberrations during progression of colorectal tumors revealed by a combined fluorescence in situ hybridization and DNA ploidy analysis of intratumoral heterogeneity.
Katsura K; Sugihara H; Nakai S; Fujita S
Cancer Genet Cytogenet; 1996 Sep; 90(2):146-53. PubMed ID: 8830725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
